China Biotech Licensing Deals Surge Past 52 Billion Dollars in Early 2026

China Biotech Licensing Deals Surge Past 52 Billion Dollars in Early 2026

  • March 4, 2026

China’s biotechnology sector has recorded a sharp rise in international licensing deals during the opening months of 2026, highlighting the country’s growing influence in global pharmaceutical research and drug development. The total value of outlicensing agreements signed by Chinese biotech companies in the

China Biotech Licensing Set for Record Year as Global Pharma Hunts New Drug Pipelines

China Biotech Licensing Set for Record Year as Global Pharma Hunts New Drug Pipelines

  • February 13, 2026

China’s biotechnology sector is on track for another record year in licensing activity as global pharmaceutical companies intensify their search for innovative drug candidates to offset looming patent expirations and rising research costs. Data from industry tracker Pharmcube shows that out licensing deals